Form 4 BioLargo Inc For: 7 July
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BioLargo Inc (BLGO)
The BioLargo share price today is 0.1081, view OTC BLGO stock exchange data. Track the latest BioLargo share price with real-time updates on BLGO stock performance including market cap, day range, 52-week range and dividend yield. Access BLGO charts, earnings dates and analyst estimates to support your investment decisions.
OTC Markets
Currency in USD
0.1081
-0.0060(-5.26%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1070
0.1157
52 wk Range
0.0950
0.2337
BLGO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.10700.1157
52 wk Range
0.09500.2337
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BLGO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
0.3200
Upside
+196.02%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
- Form 8K BioLargo Inc For: 25 March
- Investing.com
- Form 4 BioLargo Inc For: 2 July
- Investing.com
- Form 8K BioLargo Inc For: 5 March
- Investing.com
- Form 4 BioLargo Inc For: 24 June
- Investing.com
- Form 4 BioLargo Inc For: 7 July
- Investing.com
- Form 4 BioLargo Inc For: 2 July
- Investing.com
- Form 4 BioLargo Inc For: 24 June
- Investing.com
- Form 8K BioLargo Inc For: 6 May
- Investing.com
- Form S-1 BioLargo Inc For: 9 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.3200
(+196.02% Upside)
BioLargo Inc Earnings Call Summary for Q4/2025
- BioLargo reported $10.8M revenue for 2025, down 42% YoY, with a net loss of $15.2M driven by Pooph licensing termination and restructuring.
- Service revenue doubled to $2M, while the company maintained $3.9M cash position through disciplined financial management and avoiding toxic debt.
- Stock fell 5.32% in pre-market to $0.1796, near 52-week low, down 31% over past year amid profitability concerns and operational headwinds.
- 2026 guidance projects quarterly revenue of $1.1M-$1.3M with EPS of -$0.01; focus on Clyra Medical and AEC Water Treatment commercialization.
- CEO Calvert emphasized surviving Pooph transition period, though analysts warn of rapid cash burn and continued unprofitability ahead.
Last Updated: 05-03-2026, 11:24 pm
Read Full TranscriptEarnings
Latest Release
20-05-2026
EPS / Forecast
-0.01 / -0.01
Revenue / Forecast
1.12M / 1.1M
Compare BLGO to Peers and Sector
Metrics to compare | BLGO | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipBLGOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.7x | 16.1x | 3.5x | |
PEG Ratio | 0.01 | −0.69 | 0.00 | |
Price/Book | 19.5x | 1.8x | 1.6x | |
Price / LTM Sales | 6.2x | 1.1x | 1.3x | |
Upside (Analyst Target) | 196.0% | 38.1% | 47.3% | |
Fair Value Upside | Unlock | 9.0% | 3.3% | Unlock |
BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company’s technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. BioLargo, Inc. is based in Westminster, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the BioLargo (BLGO) Share Price Today?
The BioLargo share price today is 0.1081.
What is the current BioLargo (BLGO) share price and day range?
As of 19-07-2026, the BioLargo share price is 0.1081, with a previous close of 0.1141. The share price has ranged from 0.1070 to 0.1157 today, while the 52-week range spans from 0.0950 to 0.2337.
What Is the BioLargo Market Cap?
As of today, BioLargo market cap is 34.7400M.
What Is the BioLargo (BLGO) Share Price Target?
The average 12-month share price target for BioLargo is 0.3200, with a high estimate of 0.32 and a low estimate of 0.32. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +196.02% Upside potential.
What Is BioLargo's Earnings Per Share (TTM)?
The BioLargo EPS (TTM) is -0.0415.
When Is the Next BioLargo Earnings Date?
BioLargo will release its next earnings report on 18-08-2026.
From a Technical Analysis Perspective, Is BLGO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does BioLargo Trade On?
BioLargo is listed and trades on the OTC Markets.
What Is the Stock Symbol for BioLargo?
The stock symbol for BioLargo is "BLGO."
How Many Times Has BioLargo Stock Split?
BioLargo has split 1 times.
How Many Employees Does BioLargo Have?
BioLargo has 45 employees.
What Is the BLGO After Hours Price?
BLGO's last after hours stock price is 0.2250, the stock has changed by 0.0002, or 0.0900%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.